Last updated 16 days ago
A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Pediatric Participants With Moderate to Severe Plaque Psoriasis
153 patients around the world
Available in Argentina, Spain
Bristol-Myers Squibb
1Research sites
153Patients around the world
This study is for people with
Psoriasis
Plaque psoriasis
Requirements for the patient
To 18 Years
All Gender
Medical requirements
SponsorBristol-Myers Squibb
Study typeInterventional
Conditions
Plaque psoriasis
Requirements
To 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT04772079
